✦ LIBER ✦

Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens

✍ Scribed by E. Bajetta; M. Di Bartolomeo; L. Somma; M. Del Vecchio; S. Artale; F. Zunino; P. Bignami; E. Magnani; R. Buzzoni

Book ID: 117663694
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 517 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00491-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

705 Doxifluridine in patients with 5-FU

705 Doxifluridine in patients with 5-FU resistant colorectal cancer

✍ E. Bajetta; M. Di Bartolomeo; L. Somma; G. Vicario; L. Celio; P. Bignami; E. Ban 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 165 KB

The pharmacokinetics of doxifluridine an

The pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancer

✍ L. J. Schaaf; B. R. Dobbs; I. R. Edwards; D. G. Perrier 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 671 KB

Modulated 5-Fluorouracil (5-FU) Regimens

Modulated 5-Fluorouracil (5-FU) Regimens in Advanced Colorectal Cancer: A Critical Review of Comparative Studies

✍ R. Labianca; A. Pessi; G. Facendola; M. Pirovano; G. Luporini 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 680 KB

Relationship between 5-fluorouracil (5-F

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

✍ Erick C. Gamelin; Etienne M. Danquechin-Dorval; Yvan F. Dumesnil; Philippe J. Ma 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

## BACKGROUND. A phase I1 prospective trial was carried out to study the concept of 5-fluorouracil (5-FU) dose-intensity in patients with advanced colorectal cancer. Forty patients were treated with 5-FU plus leucovorin (LV), with individually increasing doses of 5-FU. A 5-FU pharmacokinetic follo

Clinical activity and benefit of irinote

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

✍ E Van Cutsem; D Cunningham; W.W Ten Bokkel Huinink; C.J.A Punt; C.G Alexopoulos; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 89 KB

760 Methotrexate (MTX) and 5-fluorouraci

760 Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU

✍ P. Pronzato; F. Vaira; A. Viganni; P. Losardo; G. Bertelli 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 122 KB